Active Shingles Infection as Detected on (18)F-FDG PET/CT

Razi Muzaffar1, Mark Fesler, Medhat M Osman

  • 1Division of Nuclear Medicine, Department of Radiology, Saint Louis University St. Louis, MO, USA.

Insights

A painful rash in a lymphoma patient undergoing chemotherapy was diagnosed as Varicella zoster infection. Follow-up PET-CT scans revealed temporary increased metabolic activity in the affected area, highlighting the importance of differentiating this from malignancy.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Dermatology

Background:

  • Follicular lymphoma patients undergoing chemotherapy may present with various complications.
  • Varicella zoster infection can manifest with cutaneous and sometimes systemic symptoms.
  • 18F-FDG PET-CT is a crucial imaging modality for lymphoma staging and monitoring treatment response.

Purpose of the Study:

  • To report a case of increased metabolic activity on 18F-FDG PET-CT secondary to Varicella zoster infection in a lymphoma patient.
  • To emphasize the importance of distinguishing post-herpetic 18F-FDG uptake from malignant metastasis.
  • To highlight the transient nature of this imaging finding.

Main Methods:

  • A 56-year-old male with recurrent follicular lymphoma was evaluated with serial 18F-FDG PET-CT scans.
  • The patient developed a rash diagnosed as Varicella zoster infection.
  • Imaging findings were correlated with clinical presentation and follow-up scans.

Main Results:

  • Initial 18F-FDG PET-CT demonstrated a dermatomal band of increased metabolic activity in the upper back, corresponding to the site of Varicella zoster eruption.
  • This abnormal uptake resolved on subsequent 18F-FDG PET-CT scans performed 4 months later.
  • The finding was successfully differentiated from tumor recurrence or metastasis.

Conclusions:

  • Varicella zoster infection can cause focal, transient 18F-FDG uptake on PET-CT scans.
  • Radiologists and clinicians must consider post-infectious inflammatory changes to avoid misinterpreting them as malignancy in patients with a history of cancer.
  • Awareness of this imaging pitfall is crucial for accurate patient management.